What is Bad Blood?
Bad Blood operates as a premier digital authority within the vaping ecosystem, providing comprehensive reviews and analytical insights into e-liquids, CBD, and THC products. By bridging the gap between complex product specifications and consumer needs, the company serves as a critical touchpoint for enthusiasts and DIY e-juice practitioners alike. Its market position is defined by a commitment to quality, variety, and informed consumer advocacy, effectively capturing a diverse audience seeking clarity in a rapidly evolving regulatory and product environment.
How much funding has Bad Blood raised?
Bad Blood has raised a total of $89K across 1 funding round:
Debt
$89K
Debt (2021): $89K with participation from PPP
Key Investors in Bad Blood
PPP
Public-Private Partnership
What's next for Bad Blood?
With the recent infusion of expansion capital, Bad Blood is poised to transition from a niche content provider to a broader digital media powerhouse. The strategic roadmap likely involves scaling its editorial operations, enhancing its data-driven review methodologies, and potentially diversifying into new segments of the wellness and alternative consumption market. As the company navigates the complexities of the vaping industry, this capital will be instrumental in fortifying its infrastructure and expanding its reach to meet the growing demand for transparent, high-quality product intelligence.
See full Bad Blood company page
